PubMed:19025767 / 843-918
Annnotations
c_corpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T75 | 6-11 | PR:Q5S006 | denotes | LRRK2 |
| T76 | 6-11 | PR:000003033 | denotes | LRRK2 |
| T77 | 6-11 | PR:Q5S007 | denotes | LRRK2 |
PMID_GLOBAL
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T19 | 72-74 | DiseaseOrPhenotypicFeature | denotes | PD | 0008199|0015873|0005180 |
PubMed_ArguminSci
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T6 | 0-75 | DRI_Challenge | denotes | Thus, LRRK2 has emerged as a promising therapeutic target for combating PD. |